Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings yield high or low?
The earnings yield of 6.72% is 22% above its 1-year average of 5.51%, near the high end of its 1-year range (4.74%–6.72%).
As of 2026-10-06T17:37:19.110Z.
Calculation as of: 2026-10-06T17:37:19.110Z.
Quote observation: 2026-10-06T17:35:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f5440d38f147f42472ad3502ccef0af83b0bc0ea844c0df361be04396bb1fdd1
EARNINGS YIELD
6.72%
EARNINGS YIELD AVG TTM
N/A
EARNINGS YIELD AVG 3Y
N/A
EARNINGS YIELD AVG 5Y
N/A
EARNINGS YIELD AVG 10Y
N/A
EARNINGS YIELD AVG 15Y
N/A
EARNINGS YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.95%
median of 180 covered companies
CURRENT VS SECTOR MEDIAN
+70.34%
vs the sector median at left
Market Cap
$981.85M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$973.03M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$971.38M
Earnings Yield
1.42%
TTM Avg
1.18%
3Y Avg
2.75%
5Y Avg
2.30%
Market Cap
$995.23M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.01B
Earnings Yield
N/A
TTM Avg
17.88%
3Y Avg
17.88%
5Y Avg
17.88%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MeiraGTx Holdings plc (MGTX) | $977.85M | 6.72% | N/A | N/A | N/A |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $981.85M | N/A | N/A | N/A | N/A |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $973.03M | N/A | N/A | N/A | N/A |
| Pacira BioSciences, Inc. (PCRX)vs › | $971.38M | 1.42% | 1.18% | 2.75% | 2.30% |
| Aktis Oncology, Inc. (AKTS)vs › | $965.56M | N/A | N/A | N/A | N/A |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $995.23M | N/A | N/A | N/A | N/A |
| Savara Inc. (SVRA)vs › | $947.79M | N/A | N/A | N/A | N/A |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.01B | N/A | 17.88% | 17.88% | 17.88% |
| Kura Oncology, Inc. (KURA)vs › | $942.07M | N/A | N/A | N/A | N/A |
| Seaport Therapeutics, Inc. Common Stock (SPTX)vs › | $940.80M | N/A | N/A | N/A | N/A |
Earnings Yield
6.72%
EPS ÷ Price
P/E Ratio
14.9
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS YIELD |
|---|---|
| 2026-10-05 | 6.50% |
| 2026-10-02 | 6.58% |
| 2026-10-01 | 6.66% |
| 2026-09-30 | 6.45% |
| 2026-09-29 | 6.38% |
| 2026-09-28 | 6.39% |
| 2026-09-25 | 6.51% |
| 2026-09-24 | 6.43% |
| 2026-09-23 | 6.04% |
| 2026-09-22 | 5.75% |
| 2026-09-21 | 5.43% |
| 2026-09-18 | 5.36% |
| 2026-09-17 | 5.44% |
| 2026-09-16 | 5.56% |
| 2026-09-15 | 5.56% |
| 2026-09-14 | 5.51% |
| 2026-09-11 | 5.55% |
| 2026-09-10 | 5.53% |
| 2026-09-09 | 5.35% |
| 2026-09-08 | 5.25% |
| 2026-09-04 | 5.11% |
| 2026-09-03 | 5.08% |
| 2026-09-02 | 5.05% |
| 2026-09-01 | 5.00% |
| 2026-08-31 | 5.14% |
| 2026-08-28 | 5.14% |
| 2026-08-27 | 5.02% |
| 2026-08-26 | 4.88% |
| 2026-08-25 | 4.76% |
| 2026-08-24 | 4.79% |
| 2026-08-21 | 4.95% |
| 2026-08-20 | 4.88% |
| 2026-08-19 | 4.74% |
| 2026-08-18 | 5.11% |
| 2026-08-17 | 5.16% |
| 2026-08-14 | 5.25% |
